NARDINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 6.287
EU - Europa 4.170
AS - Asia 2.849
SA - Sud America 311
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 4
Totale 13.673
Nazione #
US - Stati Uniti d'America 6.217
IT - Italia 1.560
GB - Regno Unito 1.107
CN - Cina 1.061
SG - Singapore 883
SE - Svezia 449
HK - Hong Kong 336
DE - Germania 271
BR - Brasile 252
TR - Turchia 219
UA - Ucraina 178
FI - Finlandia 140
RU - Federazione Russa 121
VN - Vietnam 115
FR - Francia 82
KR - Corea 70
BG - Bulgaria 63
NL - Olanda 49
IN - India 44
CA - Canada 36
AR - Argentina 27
MX - Messico 24
ID - Indonesia 21
IR - Iran 21
PL - Polonia 21
LT - Lituania 20
BE - Belgio 17
IE - Irlanda 16
ES - Italia 15
ZA - Sudafrica 15
BD - Bangladesh 14
EU - Europa 12
IQ - Iraq 11
SI - Slovenia 11
AT - Austria 10
CH - Svizzera 10
CO - Colombia 9
JP - Giappone 8
EC - Ecuador 6
MA - Marocco 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
GR - Grecia 4
MY - Malesia 4
PK - Pakistan 4
PY - Paraguay 4
UZ - Uzbekistan 4
AU - Australia 3
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
GE - Georgia 3
JO - Giordania 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
UY - Uruguay 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BO - Bolivia 2
CU - Cuba 2
CY - Cipro 2
KG - Kirghizistan 2
LV - Lettonia 2
MG - Madagascar 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
TH - Thailandia 2
AL - Albania 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MR - Mauritania 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 13.673
Città #
Southend 832
Santa Clara 800
Singapore 602
Ashburn 511
Woodbridge 496
Fairfield 433
Chandler 429
Jacksonville 353
Hong Kong 333
Hefei 332
Houston 263
Ann Arbor 260
Nyköping 246
Dearborn 234
Beijing 211
Wilmington 197
Seattle 172
London 156
Cambridge 150
Rome 138
Dallas 133
Milan 129
Izmir 120
Los Angeles 102
Helsinki 75
Princeton 70
Seoul 69
Naples 67
San Jose 66
New York 63
Sofia 62
Buffalo 61
Eugene 61
San Diego 61
The Dalles 59
Modena 53
Chicago 52
Shanghai 51
Frankfurt am Main 44
Ho Chi Minh City 43
Des Moines 37
Moscow 36
Munich 36
Bologna 32
Bari 31
Florence 29
Palermo 29
São Paulo 27
Council Bluffs 23
Hanoi 23
Philadelphia 22
Guangzhou 21
Turin 21
Catania 18
Brescia 17
Brussels 16
Dublin 16
Elk Grove Village 16
Redwood City 16
Salt Lake City 16
Columbus 15
San Mateo 15
Atlanta 14
Augusta 14
Phoenix 14
Boardman 13
Chennai 12
Mexico City 12
Nanjing 12
Norwalk 12
Stockholm 12
Tampa 12
Jakarta 11
Kent 11
Parma 11
Warsaw 11
Brooklyn 10
Falls Church 10
Kunming 10
Mashhad 10
Orem 10
Ottawa 10
Rio de Janeiro 10
Toronto 10
Verona 10
Bremen 9
Changsha 9
Denver 9
Grafing 9
Johannesburg 9
Montreal 9
Perugia 9
Pescara 9
Ardabil 8
Cosenza 8
Da Nang 8
Padova 8
Poplar 8
Sterling 8
Treviso 8
Totale 9.490
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.595
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 335
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 282
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 268
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 268
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 265
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 254
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 254
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 253
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 249
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 243
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 241
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 238
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 237
Detectable HIV viral load is associated with metabolic syndrome 236
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 233
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 231
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 230
Age-related comorbidities in people living with HIV 226
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 226
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 222
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 217
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 204
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 200
Severity of lipodystrophy is associated with decreased health-related quality of life 198
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 195
Does lipodistrophy affect quality of life? 193
Body Image perception in HIV infected women with body fat redistribution. 191
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 191
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 190
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 190
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 187
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 185
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 183
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 181
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 180
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 178
How do frailty mediate pathway leading to disability 178
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 177
È possibile un counselling HIV su internet? 176
Validity of body image perception in women with HIV. 173
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 170
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 167
Virologic failure and metabolic syndrome in patients with HIV infection 166
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 165
Virologic failure and metabolic syndrome in patients with HIV infection 162
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 160
Prevalence and risk factors of pubic lipomas in HIV-infected patients 156
Relapse of HIV-related buffalo hump after liposuction 156
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 152
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 151
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 149
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 149
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 148
Qual è il rapporto tra qualità di vita e lipodistrofia 146
HIV counselling looks for new target and methods web versus face to face counselling 146
Lipodystrophy and quality of life: a prospective study 137
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 132
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 131
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 130
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 122
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 118
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 117
HIV counselling and prevention on the WEB 117
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 94
Totale 13.794
Categoria #
all - tutte 47.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021598 0 0 0 0 0 0 109 131 82 118 95 63
2021/2022987 21 158 63 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/20252.944 117 69 73 227 624 427 221 127 337 97 294 331
2025/20262.729 335 235 509 561 579 402 108 0 0 0 0 0
Totale 13.794